Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Regulating pharmaceutical companies' financial largesse.

Avraham R, Silver C.

Isr J Health Policy Res. 2018 May 14;7(1):25. doi: 10.1186/s13584-018-0220-5. Review.

2.

scDual-Seq: mapping the gene regulatory program of Salmonella infection by host and pathogen single-cell RNA-sequencing.

Avital G, Avraham R, Fan A, Hashimshony T, Hung DT, Yanai I.

Genome Biol. 2017 Oct 27;18(1):200. doi: 10.1186/s13059-017-1340-x.

3.

Immune cell type 'fingerprints' at the basis of outcome diversity of human infection.

Hen-Avivi S, Avraham R.

Curr Opin Microbiol. 2018 Apr;42:31-39. doi: 10.1016/j.mib.2017.09.012. Epub 2017 Oct 16. Review.

PMID:
29049916
4.

Hepatic Amiodarone Lipotoxicity Is Ameliorated by Genetic and Pharmacological Inhibition of Endoplasmatic Reticulum Stress.

Erez N, Hubel E, Avraham R, Cohen R, Fishman S, Bantel H, Manns M, Tirosh B, Zvibel I, Shibolet O.

Toxicol Sci. 2017 Oct 1;159(2):402-412. doi: 10.1093/toxsci/kfx143.

PMID:
28962527
5.

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine.

Geller LT, Barzily-Rokni M, Danino T, Jonas OH, Shental N, Nejman D, Gavert N, Zwang Y, Cooper ZA, Shee K, Thaiss CA, Reuben A, Livny J, Avraham R, Frederick DT, Ligorio M, Chatman K, Johnston SE, Mosher CM, Brandis A, Fuks G, Gurbatri C, Gopalakrishnan V, Kim M, Hurd MW, Katz M, Fleming J, Maitra A, Smith DA, Skalak M, Bu J, Michaud M, Trauger SA, Barshack I, Golan T, Sandbank J, Flaherty KT, Mandinova A, Garrett WS, Thayer SP, Ferrone CR, Huttenhower C, Bhatia SN, Gevers D, Wargo JA, Golub TR, Straussman R.

Science. 2017 Sep 15;357(6356):1156-1160. doi: 10.1126/science.aah5043.

6.

Systematic, multiparametric analysis of Mycobacterium tuberculosis intracellular infection offers insight into coordinated virulence.

Barczak AK, Avraham R, Singh S, Luo SS, Zhang WR, Bray MA, Hinman AE, Thompson M, Nietupski RM, Golas A, Montgomery P, Fitzgerald M, Smith RS, White DW, Tischler AD, Carpenter AE, Hung DT.

PLoS Pathog. 2017 May 15;13(5):e1006363. doi: 10.1371/journal.ppat.1006363. eCollection 2017 May.

7.

Breaking the population barrier by single cell analysis: one host against one pathogen.

Mills E, Avraham R.

Curr Opin Microbiol. 2017 Apr;36:69-75. doi: 10.1016/j.mib.2017.01.005. Epub 2017 Feb 17. Review.

PMID:
28214736
8.

A perspective on single cell behavior during infection.

Avraham R, Hung DT.

Gut Microbes. 2016 Nov;7(6):518-525. Epub 2016 Sep 22.

9.

A highly multiplexed and sensitive RNA-seq protocol for simultaneous analysis of host and pathogen transcriptomes.

Avraham R, Haseley N, Fan A, Bloom-Ackermann Z, Livny J, Hung DT.

Nat Protoc. 2016 Aug;11(8):1477-91. doi: 10.1038/nprot.2016.090. Epub 2016 Jul 21.

PMID:
27442864
10.

Regulatory focus and adherence to self-care behaviors among adults with type 2 diabetes.

Avraham R, Van Dijk D, Simon-Tuval T.

Psychol Health Med. 2016 Sep;21(6):696-706. doi: 10.1080/13548506.2015.1112413. Epub 2015 Nov 17.

PMID:
26576471
11.

Pathogen Cell-to-Cell Variability Drives Heterogeneity in Host Immune Responses.

Avraham R, Haseley N, Brown D, Penaranda C, Jijon HB, Trombetta JJ, Satija R, Shalek AK, Xavier RJ, Regev A, Hung DT.

Cell. 2015 Sep 10;162(6):1309-21. doi: 10.1016/j.cell.2015.08.027. Epub 2015 Sep 3. Erratum in: Cell. 2015 Oct 8;163(2):523.

12.

Impact of Simulation and Clinical Experience on Self-efficacy in Nursing Students: Intervention Study.

Kimhi E, Reishtein JL, Cohen M, Friger M, Hurvitz N, Avraham R.

Nurse Educ. 2016 Jan-Feb;41(1):E1-4. doi: 10.1097/NNE.0000000000000194.

PMID:
26218009
13.

The impact of tort reform on intensity of treatment: evidence from heart patients.

Avraham R, Schanzenbach M.

J Health Econ. 2015 Jan;39:273-88. doi: 10.1016/j.jhealeco.2014.08.002. Epub 2014 Aug 13.

PMID:
25175788
14.

Role of electrodiagnosis in patients being considered for epidural steroid injections.

Annaswamy TM, Bierner SM, Avraham R.

PM R. 2013 May;5(5 Suppl):S96-9. doi: 10.1016/j.pmrj.2013.03.013. Epub 2013 Mar 19. Review.

PMID:
23524071
15.

miR-10b*, a master inhibitor of the cell cycle, is down-regulated in human breast tumours.

Biagioni F, Bossel Ben-Moshe N, Fontemaggi G, Canu V, Mori F, Antoniani B, Di Benedetto A, Santoro R, Germoni S, De Angelis F, Cambria A, Avraham R, Grasso G, Strano S, Muti P, Mottolese M, Yarden Y, Domany E, Blandino G.

EMBO Mol Med. 2012 Nov;4(11):1214-29. doi: 10.1002/emmm.201201483.

16.

Pharyngeal mesoderm regulatory network controls cardiac and head muscle morphogenesis.

Harel I, Maezawa Y, Avraham R, Rinon A, Ma HY, Cross JW, Leviatan N, Hegesh J, Roy A, Jacob-Hirsch J, Rechavi G, Carvajal J, Tole S, Kioussi C, Quaggin S, Tzahor E.

Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18839-44. doi: 10.1073/pnas.1208690109. Epub 2012 Oct 29.

17.

Context-specific microRNA analysis: identification of functional microRNAs and their mRNA targets.

Bossel Ben-Moshe N, Avraham R, Kedmi M, Zeisel A, Yitzhaky A, Yarden Y, Domany E.

Nucleic Acids Res. 2012 Nov;40(21):10614-27. doi: 10.1093/nar/gks841. Epub 2012 Sep 12.

18.

Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor.

Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y, Avni D, Leibowitz-Amit R.

Mol Cancer. 2012 Jul 2;11:44.

19.

A crossroad of microRNAs and immediate early genes (IEGs) encoding oncogenic transcription factors in breast cancer.

Sas-Chen A, Avraham R, Yarden Y.

J Mammary Gland Biol Neoplasia. 2012 Mar;17(1):3-14. doi: 10.1007/s10911-012-9243-7. Epub 2012 Feb 12.

PMID:
22327345
20.

Regulation of signalling by microRNAs.

Avraham R, Yarden Y.

Biochem Soc Trans. 2012 Feb;40(1):26-30. doi: 10.1042/BST20110623. Review.

21.

EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF.

Tarcic G, Avraham R, Pines G, Amit I, Shay T, Lu Y, Zwang Y, Katz M, Ben-Chetrit N, Jacob-Hirsch J, Virgilio L, Rechavi G, Mavrothalassitis G, Mills GB, Domany E, Yarden Y.

FASEB J. 2012 Apr;26(4):1582-92. doi: 10.1096/fj.11-194654. Epub 2011 Dec 23.

22.
23.

Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals.

Zwang Y, Sas-Chen A, Drier Y, Shay T, Avraham R, Lauriola M, Shema E, Lidor-Nili E, Jacob-Hirsch J, Amariglio N, Lu Y, Mills GB, Rechavi G, Oren M, Domany E, Yarden Y.

Mol Cell. 2011 May 20;42(4):524-35. doi: 10.1016/j.molcel.2011.04.017.

24.

Do stress responses promote leukemia progression? An animal study suggesting a role for epinephrine and prostaglandin-E2 through reduced NK activity.

Inbar S, Neeman E, Avraham R, Benish M, Rosenne E, Ben-Eliyahu S.

PLoS One. 2011 Apr 29;6(4):e19246. doi: 10.1371/journal.pone.0019246.

25.

Feedback regulation of EGFR signalling: decision making by early and delayed loops.

Avraham R, Yarden Y.

Nat Rev Mol Cell Biol. 2011 Feb;12(2):104-17. doi: 10.1038/nrm3048. Review.

PMID:
21252999
26.

EGF decreases the abundance of microRNAs that restrain oncogenic transcription factors.

Avraham R, Sas-Chen A, Manor O, Steinfeld I, Shalgi R, Tarcic G, Bossel N, Zeisel A, Amit I, Zwang Y, Enerly E, Russnes HG, Biagioni F, Mottolese M, Strano S, Blandino G, Børresen-Dale AL, Pilpel Y, Yakhini Z, Segal E, Yarden Y.

Sci Signal. 2010 Jun 1;3(124):ra43. doi: 10.1126/scisignal.2000876.

27.

Synergism between immunostimulation and prevention of surgery-induced immune suppression: an approach to reduce post-operative tumor progression.

Avraham R, Benish M, Inbar S, Bartal I, Rosenne E, Ben-Eliyahu S.

Brain Behav Immun. 2010 Aug;24(6):952-8. doi: 10.1016/j.bbi.2010.03.010. Epub 2010 Mar 31.

28.

Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor.

Glasner A, Avraham R, Rosenne E, Benish M, Zmora O, Shemer S, Meiboom H, Ben-Eliyahu S.

J Immunol. 2010 Mar 1;184(5):2449-57. doi: 10.4049/jimmunol.0903301. Epub 2010 Feb 1.

29.

Blood transfusion promotes cancer progression: a critical role for aged erythrocytes.

Atzil S, Arad M, Glasner A, Abiri N, Avraham R, Greenfeld K, Rosenne E, Beilin B, Ben-Eliyahu S.

Anesthesiology. 2008 Dec;109(6):989-97. doi: 10.1097/ALN.0b013e31818ddb72.

30.

Delayed Presentations of Blunt Mesenteric and Intestinal Trauma in the Wake of Injury.

Yair E, Miklosh B, Orit P, Avraham R, Gidon A.

Eur J Trauma Emerg Surg. 2008 Jun;34(3):249-54. doi: 10.1007/s00068-007-7045-1. Epub 2007 Oct 15.

PMID:
26815745
31.

Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis.

Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, Ben-Eliyahu S.

Ann Surg Oncol. 2008 Jul;15(7):2042-52. doi: 10.1245/s10434-008-9890-5. Epub 2008 Apr 9.

33.

Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma.

Cohen Y, Merhavi-Shoham E, Avraham RB, Frenkel S, Pe'er J, Goldenberg-Cohen N.

Exp Eye Res. 2008 Feb;86(2):201-6. Epub 2007 Nov 4.

PMID:
18068703
34.

A reciprocal tensin-3-cten switch mediates EGF-driven mammary cell migration.

Katz M, Amit I, Citri A, Shay T, Carvalho S, Lavi S, Milanezi F, Lyass L, Amariglio N, Jacob-Hirsch J, Ben-Chetrit N, Tarcic G, Lindzen M, Avraham R, Liao YC, Trusk P, Lyass A, Rechavi G, Spector NL, Lo SH, Schmitt F, Bacus SS, Yarden Y.

Nat Cell Biol. 2007 Aug;9(8):961-9. Epub 2007 Jul 22.

PMID:
17643115
35.

Prophylactic IL-12 treatment reduces postoperative metastasis: mediation by increased numbers but not cytotoxicity of NK cells.

Schwartz Y, Avraham R, Benish M, Rosenne E, Ben-Eliyahu S.

Breast Cancer Res Treat. 2008 Jan;107(2):211-23. Epub 2007 Mar 13.

PMID:
17431763
36.

Immune suppression while awaiting surgery and following it: dissociations between plasma cytokine levels, their induced production, and NK cell cytotoxicity.

Greenfeld K, Avraham R, Benish M, Goldfarb Y, Rosenne E, Shapira Y, Rudich T, Ben-Eliyahu S.

Brain Behav Immun. 2007 May;21(4):503-13. Epub 2007 Feb 12.

PMID:
17293081
37.

CHK negatively regulates Lyn kinase and suppresses pancreatic cancer cell invasion.

Fu Y, Zagozdzon R, Avraham R, Avraham HK.

Int J Oncol. 2006 Dec;29(6):1453-8.

PMID:
17088984
38.

Medical malpractice and patient safety.

Avraham R.

N Engl J Med. 2006 Aug 17;355(7):735; author reply 736. No abstract available.

PMID:
16921589
39.

Autologous control of a highly malignant syngeneic CRNK-16 leukemia in the rat: a role for NK cells.

Avraham R, Inbar S, Rosenne E, Ben-Eliyahu S.

Cancer Immunol Immunother. 2006 Nov;55(11):1348-57. Epub 2006 Feb 8.

PMID:
16465528
40.

Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.

Torimura T, Ueno T, Kin M, Harada R, Nakamura T, Kawaguchi T, Harada M, Kumashiro R, Watanabe H, Avraham R, Sata M.

Hepatology. 2001 Jul;34(1):62-71.

PMID:
11431735
41.

[Ovarian cancer in Israel, 1960-1989].

Mor-Yosef S, Avraham R, Schenker JG.

Harefuah. 1997 Feb 2;132(3):153-5, 240. Hebrew.

PMID:
9154717
42.

[Kapoera--popular dance or martial art?].

Kluger Y, Ravid A, Ben Avraham R, Soffer D, Aladgem D.

Harefuah. 1997 Jan 15;132(2):137-8, 151. Hebrew.

PMID:
9119300
44.

Humoral and cellular responses in calves experimentally infected with bovine leukemia virus (BLV).

Meiron R, Brenner J, Gluckman A, Avraham R, Trainin Z.

Vet Immunol Immunopathol. 1985 Jun;9(2):105-14.

PMID:
2994281
45.

The specificity and kinetic properties of trypsin ethylated at the binding site.

Ben Avraham R, Shalitin Y.

FEBS Lett. 1985 Jan 28;180(2):239-42.

46.

Reduced immunocompetence of antibodies produced in leukemic cattle.

Ungar-Waron H, Avraham R, Gluckmann A, Trainin Z.

Ann Rech Vet. 1978;9(4):815-9. No abstract available.

PMID:
754649

Supplemental Content

Loading ...
Support Center